Since fibroblasts are key IL-6 producers in pancreatic cancer (Fig. 1C, D), we investigated whether treatment with the TGFβ vaccine could increase IL-6 production in this population, driving the elevated IL-6 levels in TCM. Here, IL6 is linked to familial pancreatic carcinoma.